Iodine prophylaxis around the Semipalatinsk Nuclear Testing Site, Republic of Kazakstan

Public Health Nutrition

Volumn 6, Issue 8, 2003, Pages 785-789

  Hamada, Aiko ^a   Zakupbekova, Mairash ^b   Sagandikova, Sagadat ^b   Espenbetova, Maira ^c   Ohashi, Toshinori ^d   Takamura, Noboru ^a   Yamashita, Shunichi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Semipalatinsk Diagnostic Center   (Kazakhstan)

^c SEMEY MEDICAL UNIVERSITY   (Kazakhstan)

^d High Performance Materials Department   (Japan)

Author keywords

Iodine deficiency disorders; Semipalatinsk; Universal salt iodisation; Urinary iodine

Indexed keywords

IODINE; SODIUM CHLORIDE;

ADOLESCENT; ADULT; ARTICLE; ATOMIC BOMB; CHILD; FALLOUT; FEMALE; HUMAN; IODINE DEFICIENCY; KAZAKHSTAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RADIOACTIVE CONTAMINATION; RISK ASSESSMENT; URINE LEVEL;

ADOLESCENT; ADULT; AIR POLLUTANTS, RADIOACTIVE; CHILD; ENVIRONMENTAL EXPOSURE; HUMANS; IODINE; KAZAKHSTAN; MASS SCREENING; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; PREMEDICATION; RADIOACTIVE FALLOUT; SODIUM CHLORIDE, DIETARY; THYROID DISEASES;

EID: 0348010604     PISSN: 13689800     EISSN: None     Source Type: Journal    
DOI: 10.1079/PHN2003496     Document Type: Article

References (22)

1. Gilbert ES, Land CE, Simon SL. Health effects from fallout. Health Physics 2002; 82(5): 726-35.
2. Nagataki S, Shibata Y, Inoue S, Yokoyama N, Izumi M, Shimaoka K. Thyroid diseases among atomic bomb survivors in Nagasaki. Journal of the American Medical Association 1994; 272(5): 364-70.
3. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiation Research 1994; 137(Suppl. 2): S17-67.
4. Robbins J, Schneider AB. Thyroid cancer following exposure to radioactive iodine. Reviews in Endocrine & Metabolic Disorders 2000; 1(3): 197-203
5. Yamamoto M, Tsukatani T, Katayama Y. Residual radioactivity in the soil of the Semipalatinsk Nuclear Test Site in the former USSR. Health Physics 1996; 71(2): 142-8.
6. Simon SL, Bouville A. Radiation doses to local populations near nuclear weapons test sites worldwide. Health Physics 2002; 82(5): 706-25.
7. Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chernobyl. Nature 1992; 359(6390): 21.
8. Shibata Y, Yamashita S, Masyakin VB, Panasyuk GD, Nagataki S. 15 years after Chernobyl: new evidence of thyroid cancer. Lancet 2001; 358(9297): 1965-6.
9. Dedov II. Endemic goiter in the former USSR: problems and solutions. IDD Newsletter 1992; 8(1): 2-4.
10. Zelster ME, Aidarkhanov BA, Berezhnaya IM, Speransly GG, Bazarbekova RB, Nurbetova AA, et al. Iodine deficiency and its clinical manifestations in Kazakhstan. IDD Newsletter 1992; 8(1): 10-2.
11. Gerasimov G. IDD in Eastern Europe and Central Asia. IDD Newsletter 2002; 18(3): 33-7.
12. Hamada A, Takamura N, Meirmanov S, Alipov G, Mine M, Ruslan E, et al. No evidence of radiation risk for thyroid gland among schoolchildren around Semipalatinsk Nuclear Testing Site. Endocrine Journal 2003; 50(1): 85-9.
13. Bourdoux P. Evaluation of the iodine intake: problems of the iodine/creatinine ratio - comparison with iodine excretion and daily fluctuations of iodine concentration. Experimental and Clinical Endocrinology & Diabetes 1998; 106(Suppl. 3): S17-20.
14. Ohashi T, Yamaki M, Pandav CS, Karmarkar MG, Irie M. Simple microplate method for determination of urinary iodine. Clinical Chemistry 2000; 46(4): 529-36.
15. Soldin OP. Controversies in urinary iodine determinations. Clinical Biochemistry 2002; 35(8): 575-9.
16. World Health Organization (WHO)/United Nations Children's Emergency Fund (UNICEF)/International Council for the Control of Iodine Deficiency Disorders (ICCIDD). Indicators for Assessing Iodine Deficiency Disorders and their Control Through Salt Iodization. WHO/NUT/94.6. WHO/UNICEF/ICCIDD, 1994 [unpublished].
17. Ishigaki K, Namba H, Takamura N, Saiwai H, Parshin V, Ohashi T, et al. Urinary iodine levels and thyroid diseases in children; comparison between Nagasaki and Chernobyl. Endocrine Journal 2001; 48(5): 591-5.
18. Francois D, Burgi H, Chen ZP, Dunn JT. World status of monitoring iodine deficiency disorders control programs. Thyroid 2002; 12(10): 915-24.
19. Ashizawa K, Shibata Y, Yamashita S, Namba H, Hoshi M, Yokoyama N, et al. Prevalence of goiter and urinary iodine excretion levels in children around Chernobyl. Journal of Clinical Endocrinology and Metabolism 1997; 82(10): 3430-3.
20. Gerasimov G. The challenge ahead: iodized salt on every table for ever. Bulletin of the World Health Organization 2002; 80(8): 413-4.
21. Robbins J, Dunn JT, Bouville A, Kravchenko VI, Lubin J, Petrenko S, et al. Iodine nutrition and the risk from radioactive iodine: a workshop report in the Chernobyl Long Term Follow-Up Study. Thyroid 2001; 11(5): 487-91.
22. World Health Organization (WHO)/United Nations Children's Emergency Fund (UNICEF)/International Council for the Control of Iodine Deficiency Disorders (ICCIDD). Assessment of Iodine Deficiency Disorders and Monitoring their Elimination. WHO/NUT/01.1. WHO/UNICEF/ICCIDD, 2001 [unpublished].